INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Key Stats

• Today's Range: $2.00 to $2.35
• 50-Day Range: $2.19 to $6.54
• 52-Week Range: $2.00 to $51.12
• Volume: 649,456 shs
• Average Volume: 2.80 million shs
• Market Capitalization: $1.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVF Stock Analysis - Frequently Asked Questions

How have IVF shares performed this year?

INVO Fertility's stock was trading at $29.16 on January 1st, 2025. Since then, IVF shares have decreased by 92.3% and is now trading at $2.24.

How were INVO Fertility's earnings last quarter?

INVO Fertility, Inc (NASDAQ:IVF) released its quarterly earnings data on Monday, November, 15th. The company reported ($172.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($144.00) by $28.80. The firm had revenue of $0.22 million for the quarter, compared to the consensus estimate of $0.25 million.

When did INVO Fertility's stock split?

Shares of INVO Fertility reverse split on the morning of Monday, July 21st 2025.The 1-3 reverse split was announced on Monday, July 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

How do I buy shares of INVO Fertility?

Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/15/2021
• Today: 7/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IVF
• Previous Symbol: NASDAQ:INVO
• CIK: 1417926
• Web: www.invobioscience.com
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 25
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($102.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.10 million
• Net Margins: -377.73%
• Pretax Margin: -378.10%
• Return on Equity: N/A
• Return on Assets: -88.18%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.08
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $6.53 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($89.58) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 720,000
• Free Float: 716,000
• Market Cap: $1.61 million
• Optionable: No Data
• Beta: 2.04